Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management.

Gervais DA, Arellano RS, Mueller PR

Department of Radiology, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, MA 02114, USA.

OBJECTIVE: Stages III and IV ovarian cancer are treated with a combination of chemotherapy and resection, in some cases including second and third surgical procedures, to achieve cytoreduction. Percutaneous radiofrequency ablation has proved effective in local control of hepatic tumors. We report early experience with percutaneous radiofrequency ablation in the management of isolated foci of metastatic ovarian cancer and assess the efficacy of the technique in achieving and maintaining local control by percutaneous cytoreduction. CONCLUSION: Percutaneous radiofrequency ablation is effective in achieving local control in selected patients with metastasis from ovarian cancer. In patients with limited macroscopic disease, cytoreduction can be achieved without surgery.

Published 24 August 2006 in AJR Am J Roentgenol, 187(3): 746-50.
Full-text of this article is available online (may require subscription).

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.